SARS News and Research

RSS

Development of 18 monoclonal antibodies against 9 SARS-CoV-2 proteins

A new study aimed to generate, characterize, and optimize Abs against SARS-CoV-2 proteins.

12 Apr 2022

Dysregulated retroelements associated with autoimmunity in COVID-19

Researchers investigate potential interactions between retro-elements shared between the human and coronavirus genomes.

12 Apr 2022

Severe COVID-19 extremely rare among children

A new Journal of Infection study describes the findings in children who contracted SARS-CoV-2 infection in England.

12 Apr 2022

Does COVID-19 vaccination affect IVF treatments?

A new study assesses the impact of COVID-19 vaccination in women undergoing assisted reproduction.

12 Apr 2022

New COVID-19 vaccine induces T-cell immune responses in most patients with B-cell deficiencies

CoVac-1, a new vaccine against SARS-CoV-2, induced T-cell immune responses in 93 percent of patients with B-cell deficiencies, including many patients with leukemia and lymphoma, according to results presented at the AACR Annual Meeting 2022, held April 8-13.

12 Apr 2022

Aprotinin could inhibit virus replications by preventing SARS-CoV-2 entry into host cells

A clinical study from Spain recently confirmed laboratory experiments made by researchers of Goethe University Frankfurt and University of Kent who showed that the protease inhibitor aprotinin prevented cells to be infected by SARS-CoV2.

12 Apr 2022

Injection-free dermally delivered subunit vaccine strongly neutralizes SARS-CoV-2 variants

Researchers in Australia have evaluated the vaccine candidature of HexaPro S protein subunit vaccine against SARS-CoV-2.

12 Apr 2022

Decoy nanoparticles could provide a quick, effective treatment for COVID-19

They might look like cells and act like cells. But a new potential COVID-19 treatment is actually a cleverly disguised trickster, which attracts viruses and binds them, rendering them inactive.

12 Apr 2022

Heart complications uncommon for children and young adults after SARS-CoV-2 infection

Heart complications are uncommon, yet treatable for children and young adults after COVID-19 disease or SARS-CoV-2 infection, according to a new scientific statement from the American Heart Association that details what has been learned about how to treat, manage and even prevent cardiovascular complications from the SARS-CoV-2 virus in youth.

12 Apr 2022

Study identifies risk factors for severe COVID-19 in hospitalized children in Canada

Researchers evaluated the risk factors for severe COVID-19 among hospitalized children in Canada.

12 Apr 2022

Early COVID-19 reinfections possible within 60 days of initial infection

Researchers reported that COVID-19 reinfections could occur within 60 days of the initial infection.

12 Apr 2022

Experimental tool can precisely pick out interactions between immune cell and target antigen

The human body has millions of unique B and T cells that roam the body, looking for microbial invaders. These immune cells' ability to recognize harmful microbes is critical to successfully fighting off infection.

12 Apr 2022

Study finds efficacy of SARS-CoV-2 vaccines reported in Phase 3 trials declines as pandemic prevalence at trial sites increases

A recent study published in PLoS ONE assessed the association of the prevalence of the COVID-19 pandemic with vaccine efficacy.

12 Apr 2022

Impact of face masks on COVID-19 incidence in children in Finland

A new study assessed the impact of face masks on COVID-19 incidence among children aged between 10 and 12 years in Helsinki and Turku.

12 Apr 2022

SARS-CoV-2 control measures and vaccination reduce infection risk for food workers

Researchers investigated the impact of control measures and vaccination to protect food production workers from SARS-CoV-2 infection.

12 Apr 2022

Epidemiologic characteristics of SARS-CoV-2 Omicron and Delta variant infection cases in Cantabria, Spain

Researchers performed a comparative assessment of the key epidemiological characteristics such as secondary attack rates, transmission, serial interval, and incubation period of SARS-CoV-2 infections by the Omicron and Delta variants.

12 Apr 2022

Exploring vaccine effectiveness against SARS-CoV-2 Omicron and Delta variants in adolescents

A new study assessed the effectiveness of the BNT162b2 SARS-CoV-2 vaccine against Delta and Omicron variants in adolescents.

12 Apr 2022

Colorado moves toward statewide coverage of wastewater surveillance

On a Sunday morning in March 2020, right at the start of the pandemic, an article in Popular Mechanics caught engineer Pieter Van Ry's eye. It had a catchy title: "How Poop Offers Hints About the Spread of Coronavirus."

12 Apr 2022

Safety, reactogenicity, and immunogenicity of the BNT and half-m1273 mRNA COVID-19 vaccines given as a fourth dose booster

Researchers evaluated the immunogenicity of Pfizer’s BNT162b2 and Moderna’s mRNA-1273 vaccines offered as the fourth dose against SARS-CoV-2.

12 Apr 2022

Differences in symptoms and risk of hospitalization following infection with Omicron or Delta SARS-CoV-2 variants among vaccinated people

A recent study assessed the prevalence of SARS-CoV-2 symptoms and the risk of hospitalization in vaccinated individuals infected with SARS-CoV-2 Omicron and Delta variants.

12 Apr 2022

SARS News and Research

Development of 18 monoclonal antibodies against 9 SARS-CoV-2 proteins

Dysregulated retroelements associated with autoimmunity in COVID-19

Severe COVID-19 extremely rare among children

Does COVID-19 vaccination affect IVF treatments?

New COVID-19 vaccine induces T-cell immune responses in most patients with B-cell deficiencies

Aprotinin could inhibit virus replications by preventing SARS-CoV-2 entry into host cells

Injection-free dermally delivered subunit vaccine strongly neutralizes SARS-CoV-2 variants

Decoy nanoparticles could provide a quick, effective treatment for COVID-19

Heart complications uncommon for children and young adults after SARS-CoV-2 infection

Study identifies risk factors for severe COVID-19 in hospitalized children in Canada

Early COVID-19 reinfections possible within 60 days of initial infection

Experimental tool can precisely pick out interactions between immune cell and target antigen

Study finds efficacy of SARS-CoV-2 vaccines reported in Phase 3 trials declines as pandemic prevalence at trial sites increases

Impact of face masks on COVID-19 incidence in children in Finland

SARS-CoV-2 control measures and vaccination reduce infection risk for food workers

Epidemiologic characteristics of SARS-CoV-2 Omicron and Delta variant infection cases in Cantabria, Spain

Exploring vaccine effectiveness against SARS-CoV-2 Omicron and Delta variants in adolescents

Colorado moves toward statewide coverage of wastewater surveillance

Safety, reactogenicity, and immunogenicity of the BNT and half-m1273 mRNA COVID-19 vaccines given as a fourth dose booster

Differences in symptoms and risk of hospitalization following infection with Omicron or Delta SARS-CoV-2 variants among vaccinated people

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News